Effects of combined probucol-colestipol treatment for familial hypercholesterolemia and coronary artery disease

This publication has 9 references indexed in Scilit:

• The LDL receptor locus in familial hypercholesterolemia: Multiple mutations disrupt transport and processing of a membrane receptor
  Cell, 1983
• Familial Type II Hyperlipoproteinemia with Coronary Heart Disease
  Chest, 1981
• Normalization of Low-Density-Lipoprotein Levels in Heterozygous Familial Hypercholesterolemia with a Combined Drug Regimen
  New England Journal of Medicine, 1981
• Use of combined diet and colestipol in long-term (7--7 1/2 years) treatment of patients with type II hyperlipoproteinemia.
  Circulation, 1979
• The Low-Density Lipoprotein Pathway and its Relation to Atherosclerosis
  Annual Review of Biochemistry, 1977
• Familial Hypercholesterolemia: A Genetic Defect in the Low-Density Lipoprotein Receptor
  New England Journal of Medicine, 1976
• Mode of action of a new hypocholesteraemic drug (DH-581) in familial hypercholesteraemia
  Atherosclerosis, 1972
• Hypocholesterolesmic Effect of 4,4′-(Isopropylidenedithio)-Bis(2,6-di-t-Butylphenol) (Probucol)
  The American Journal of Clinical Nutrition, 1970
• Effects of colestipol (U-26,597A), a new bile acid sequestrant, on serum lipids in experimental animals and man
  Atherosclerosis, 1970